×
About 280 results

ALLMedicine™ Migraine In Children Center

Research & Reviews  94 results

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
https://clinicaltrials.gov/ct2/show/NCT04396574

May 20th, 2022 - The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.

Randomized Study in Children and Adolescents With Migraine: Acute Treatment
https://clinicaltrials.gov/ct2/show/NCT04649242

May 12th, 2022 - The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents.

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
https://clinicaltrials.gov/ct2/show/NCT05156398

May 9th, 2022 - The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to <18 years with episodic migraine.

Attention deficit hyperactivity disorder and risk of migraine: A nationwide longitudina...
https://doi.org/10.1111/head.14306
Headache Hsu TW, Chen MH et. al.

May 8th, 2022 - This study explored the risk of migraine in children, adolescents, and young adults with attention deficit hyperactivity disorder (ADHD) and its association with ADHD medications. The prevalence of migraine peaks between the ages of 35 and 39 year...

A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and Adolescents
https://clinicaltrials.gov/ct2/show/NCT05102591

Mar 16th, 2022 - One in ten Canadian children and adolescents suffer from migraine, and visits to the pediatric emergency department (ED) for acute attacks are common, with over 2,500 annual visits in Alberta alone. Evidence-based acute management options for chil...

see more →

Guidelines  2 results

Pharmacologic Acute and Preventive Treatment for Migraine in Children and Adolescents.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074018
JAMA Neurology; Szperka CL, VanderPluym JH et. al.

Dec 10th, 2019 - Pharmacologic Acute and Preventive Treatment for Migraine in Children and Adolescents.|2019|Szperka CL,VanderPluym JH,Oakley CB,|prevention & control,

Guidelines of the International Headache Society for controlled trials of preventive tr...
https://doi.org/10.1177/0333102419842188
Cephalalgia : an International Journal of Headache; Abu-Arafeh I, Hershey AD et. al.

Apr 6th, 2019 - Because the results of clinical trials of investigational treatments influence regulatory policy, prescribing patterns, and use in clinical practice, high quality trials are an essential component of the evidence base for migraine. The Internation...

see more →

Clinicaltrials.gov  5 results

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
https://clinicaltrials.gov/ct2/show/NCT04396574

May 20th, 2022 - The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.

Randomized Study in Children and Adolescents With Migraine: Acute Treatment
https://clinicaltrials.gov/ct2/show/NCT04649242

May 12th, 2022 - The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents.

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
https://clinicaltrials.gov/ct2/show/NCT05156398

May 9th, 2022 - The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to <18 years with episodic migraine.

A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and Adolescents
https://clinicaltrials.gov/ct2/show/NCT05102591

Mar 16th, 2022 - One in ten Canadian children and adolescents suffer from migraine, and visits to the pediatric emergency department (ED) for acute attacks are common, with over 2,500 annual visits in Alberta alone. Evidence-based acute management options for chil...

Mind and Body Approaches to Pain Reduction in Youth With Migraine
https://clinicaltrials.gov/ct2/show/NCT03472092

Feb 8th, 2022 - Pediatric migraine is a prevalent disorder that results in significant pain and disability for children and adolescents. Despite the prevalence and cost, commonly used pharmacologic treatments to treat pediatric migraine have limited evidence of e...

see more →

News  11 results

Large Placebo Effect Scuppers Pediatric Headache Trials
https://www.staging.medscape.com/viewarticle/778396

Jan 29th, 2013 - High placebo response rates, coupled with a paucity of placebo-controlled trials, appear to be major obstacles in determining the efficacy of agents to successfully prevent and treat pediatric headache, 2 new studies suggest. In a systematic revie...

Migraine: Placebo Response Stymies Treatment in Kids
https://www.medpagetoday.com/painmanagement/migraines/37061

Jan 28th, 2013 - Action Points Pharmacologic therapy of migraine headache in children remains a major clinical challenge, with high placebo response rates impeding efforts to assess efficacy. Note that one study found that topiramate and trazodone have limited evi...

New Tool Aids in Diagnosis of Pediatric Migraine
https://www.medscape.com/viewarticle/777797

Jan 17th, 2013 - A new structured interview has been shown to be a reliable and valid method for detecting migraine in children and teens in both clinical and community settings. The Diagnostic Interview of Headache Syndromes–Child Version (DIHS-C) can be administ...

New Tool Aids in Diagnosis of Pediatric Migraine
https://www.staging.medscape.com/viewarticle/777797

Jan 17th, 2013 - A new structured interview has been shown to be a reliable and valid method for detecting migraine in children and teens in both clinical and community settings. The Diagnostic Interview of Headache Syndromes–Child Version (DIHS-C) can be administ...

Rizatriptan Safe, Effective for Migraine in Children
https://www.staging.medscape.com/viewarticle/766573

Jun 28th, 2012 - June 28, 2012 (Los Angeles, California) — Rizatriptan (Maxalt, Merck Sharp & Dohme Corp) is safe, effective, and well tolerated in teens and children as young as 6 years old, according to new research. Two studies of the drug in children were pres...

see more →